Publication | Open Access

Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in Europe

Pulmonary TuberculosisDrug Resistance AnalysisRifampicin-resistant TuberculosisHealth SciencesPharmacologyTuberculosisPharmacotherapyAntimicrobial ChemotherapyAntibiotic ResistanceMedicineResistance TestingClinical MicrobiologyAntimicrobial ResistanceDrug DiscoveryDrug Resistance